Nilotinib and Imatinib Are Comparably Effective in Reducing Growth of Human Eosinophil Leukemia Cells in a Newly Established Xenograft Model

We developed a xenograft model of human Chronic Eosinophilic Leukemia (CEL) to study disease progression and remission-induction under therapy with tyrosine kinase inhibitors using imatinib and nilotinib as examples. The FIP1L1/PDGFRA+ human CEL cell lineEOL-1 was injected intravenously into scid mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wicklein, Daniel, Ramos Leal, Nuno, Salamon, Johannes, Thamer, Mohammed, Herrmann, Harald, Valent, Peter, Schumacher, Udo, Ullrich, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279340/
https://www.ncbi.nlm.nih.gov/pubmed/22348015
http://dx.doi.org/10.1371/journal.pone.0030567

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3279340/
https://www.ncbi.nlm.nih.gov/pubmed/22348015
http://dx.doi.org/10.1371/journal.pone.0030567

Ejemplares similares